[Contribution to the pharmacology of the beta-adrenolytics].
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000494:pharmacology; D000772:Anesthesia, Local; D000818:Animals; D001143:Arousal / Q000187:drug effects; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001249:Asthma / Q000503:physiopathology; D002302:Cardiac Output / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D003327:Coronary Disease / Q000188:drug therapy*; D004357:Drug Synergism; D004983:Ethanolamines / Q000494:pharmacology; D006019:Glycolysis / Q000187:drug effects; D006168:Guinea Pigs; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced; D006973:Hypertension / Q000188:drug therapy; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D007328:Insulin / Q000494:pharmacology; D008053:Lipid Mobilization / Q000187:drug effects; D051379:Mice; D011433:Propranolol / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D013565:Sympatholytics / Q000494:pharmacology*
D000319:Adrenergic beta-Antagonists; D004983:Ethanolamines; D006993:Hypnotics and Sedatives; D007328:Insulin; D013565:Sympatholytics; D011433:Propranolol
Beitrag zur Pharmakologie der beta-Adrenolytika.